Wayne Rothbaum

Track

Insider profile

Currently holds a position at Iovance Biotherapeutics Inc

Performance

Overall performance
2.9
Performance over holding periods
2.9
30 days 90 days 120 days
Average return -8% 8.2% 15.1%
Success rate 7% 68% 82%
Transactions
4 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Iovance Biotherapeutics Inc June 7, 2016 -
Wayne Rothbaum's trades of Iovance Biotherapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-02-20 2024-02-20
B Purchase
37,837 -9.1%
229.39
US$4,413,604 		37,837 -9.1% 229.39 US$4,413,604
2023-09-15 2023-09-15
B Purchase
56,085 +12.1%
62.46
US$4,605,683 		56,085 +12.1% 62.46 US$4,605,683
2022-12-02 2022-12-02
B Purchase
70,051 +49.8%
429.92
US$4,535,689 		70,051 +49.8% 429.92 US$4,535,689
2022-06-02 2022-06-01
B Purchase
500,000 +6.6%
6.43
US$3,215,500 		500,000 +6.6% 6.43 US$3,215,500
2022-06-02 2022-05-31
B Purchase
500,000 +7.1%
6.77
US$3,384,550 		500,000 +7.1% 6.77 US$3,384,550